AARD - Aardvark Therapeutics Inc.
6.11
0.390 6.383%
Share volume: 181,776
Last Updated: 05-12-2026
Pharmaceutical Products/Pharmaceutical Preparations:
0.10%
PREVIOUS CLOSE
CHG
CHG%
$5.72
0.39
0.07%
View ratios
| Fiscal Date | 03-31-2025 | 09-30-2025 | 12-31-2025 | 03-31-2026 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
| Report Date | 05-14-2025 | 11-13-2025 | 03-23-2026 | 05-07-2026 | |
| Cash flow financing | 88.875 M | 171.000 K | 274.000 K | 4.000 K | |
| Other financing cash flows | 110.000 K | 171.000 K | 79.000 K | 4.000 K | |
| Cash flow | -35.137 M | 13.287 M | 7.766 M | 15.385 M | |
| Net income | -9.310 M | -16.316 M | -17.598 M | -21.588 M | |
| Depreciation | 5.000 K | 10.000 K | 10.000 K | 11.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -112.624 M | 29.246 M | 24.302 M | 34.250 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 4.000 K | 0.000 | 0.000 | |
| Cash Change | -35.137 M | 13.287 M | 7.766 M | 15.385 M |